Research & Development Market Research Reports & Industry Analysis
Bringing R&D costs and times down, therefore, means there are many opportunities to improve efficiencies, advance technological innovation, and economize and optimize. The pharmaceutical R&D category tracks both drug pipeline reports, competitive R&D strategies, and markets important and ancillary to the research efforts themselves, including activities in the biotech and sector that impinge upon the process.
Research & Development Industry Research & Market Reports
-
Synthetic Protein
... CAGR of 15.7% over the analysis period 2024-2030. The U.S. Market is Estimated at US$87.8 Million While China is Forecast to Grow at 20.2% CAGR The Synthetic Protein market in the U.S. is estimated at ... Read More
-
Soft Tissue Allografts
... at a CAGR of 4.9% over the analysis period 2024-2030. Orthopedic, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of the ... Read More
-
Bone Morphogenetic Proteins
... at a CAGR of 2.4% over the analysis period 2024-2030. Recombinant human bone morphogenetic protein-2 (rhBMP-2), one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$484.6 Million ... Read More
-
Albumin
... 3.8% over the analysis period 2024-2030. Human Serum Albumin, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$902.4 Million by the end of the analysis period. ... Read More
-
Life Science Analytics
... at a CAGR of 13.3% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$44.7 Billion by the end of the ... Read More
-
Stromal Vascular Fraction
... at a CAGR of 4.5% over the analysis period 2024-2030. Isolation Products, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$99.5 Million by the end of ... Read More
-
Protein Fractionation
... CAGR of 5.4% over the analysis period 2024-2030. Immunoglobulins, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$24.4 Billion by the end of the analysis period. ... Read More
-
Cancer Therapies
... CAGR of 10.4% over the analysis period 2024-2030. Blood Cancer, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$119.2 Billion by the end of the analysis ... Read More
-
Biotech API Manufacturing Services
... 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. API Process Development & Manufacturing, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$30.2 ... Read More
-
Quantum Computing in Healthcare
... 2030, growing at a CAGR of 36.9% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 40.1% CAGR and reach US$452.4 Million by the end ... Read More
-
Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment
... Billion by 2030, growing at a CAGR of 10.8% over the analysis period 2024-2030. Medication, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$5.5 Billion by ... Read More
-
Virus Filtration Products
... at a CAGR of 12.4% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$7.8 Billion by the end ... Read More
-
Rat Model
... CAGR of 7.1% over the analysis period 2024-2030. Inbred, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$901.6 Million by the end of the analysis period. ... Read More
-
Peptide Synthesis
... CAGR of 4.3% over the analysis period 2024-2030. Reagent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$161.7 Million by the end of the analysis period. ... Read More
-
PEGylated Proteins
... CAGR of 9.1% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$1.3 Billion by the end of the analysis period. ... Read More
-
Protein Characterization and Identification
... 2030, growing at a CAGR of 13.2% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$17.2 Billion by the end ... Read More
-
Electronic Lab Notebook Market by Deployment [Cloud (SaaS, PaaS, IaaS)], License (Proprietary, Open source), Component (Software, Services), Organization Size (SME, Large), End User (Pharma & Biotech, NGS, Biobank, Academia) - Global Forecast to 2030
... led to the widespread use of digital tools and innovative solutions. Additionally, as regulatory agencies focus more on data integrity and accuracy, adopting electronic lab notebooks (ELNs) provides organizations with a strategic advantage in meeting ... Read More
-
Biotechnology in Australia - Industry Market Research Report
... sectors, with businesses using biotech applications to address many social and economic issues, including human health, food security and alternative fuels. Several companies have reached commercial readiness, with robust product pipelines and the support of ... Read More
-
Enzymatic DNA Synthesis Market Size, Share & Trends Analysis Report By Service (Oligonucleotide Synthesis, Gene Synthesis), By Application (Synthetic Biology, Genetic Engineering), By End-use, By Region, And Segment)- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
... growing at a CAGR of 26.5% from 2024 to 2033. Enzymatic DNA Synthesis Market Key Takeaways North America dominated the market and accounted for a 50.81% share in 2023 The enzymatic DNA synthesis market in ... Read More
-
Frost Radar™: Life Sciences Real-World Evidence Solutions, 2025
... healthcare providers, and technology organizations have realized the need for real-world data (RWD) to boost research while optimizing clinical trials and improving patient outcomes. The platforms and enabling technologies help pharma/biotech companies harness regulatory-grade RWE ... Read More
-
Global Life Sciences Analytics Market 2025-2029
... sciences analytics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Medical Research in China - Industry Market Research Report
... growth has been steadily slowing in recent years as the industry has matured, and competition for government funds and private funds has increased. Over half of the industry's revenue is derived from government funding. The ... Read More
-
Global Proteasome Inhibitors Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
2025 Global Forecast for Mice Model Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 to ... Read More
-
IDC MaturityScape Benchmark: AI-Fueled Life Sciences Organization Worldwide, 2025
... differentiator. The life sciences industry is the industry that will be the most disrupted by AI. From developing innovative therapies that will fuel a precision medicine strategy to accelerating drug development, AI will be the ... Read More
Research Assistance
